jyoung
09-24-2009, 12:35 AM
Jazz Pharmaceuticals, Inc. (NASDAQ:JAZZ) shot up to $9.95, added $0.58 or 6.19% over yesterday’s closing price with an unusual volume of 1.78 million shares within an hour of trade. In the last six months the stock has surged over 870%. . The marketed products and late-stage product candidate of the Company include Xyrem (sodium oxybate) oral solution, Luvox CR (fluvoxamine maleate) extended-release capsules and JZP-6 (sodium oxybate)……………………
check out LiquidTycoon dot com bcuz they have a summary report on the company...cool site!
check out LiquidTycoon dot com bcuz they have a summary report on the company...cool site!